Additional details
Indication (or studied pathology) : Banque de sang
Brugmann identifier : CHUB-PROSPECT-TRANSFU-DREPAno Part II
EudraCT identifier :
B077201834841
ClinicalTrials.gov identifier : NCT03405688
Resources
Involved department : Clinical biology
Principal investigator : Elkenz
Sponsor : CHUB
Contact : Clinical Research Unit
This protocol was approved by the Brugmann (CE Central) ethics committee.